flumazenil has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siccha, SM | 1 |
| Cueto, AM | 1 |
| Parrón-Pajares, M | 1 |
| González-Morán, G | 1 |
| Pacio-Miguez, M | 1 |
| Del Pozo, Á | 1 |
| Solís, M | 1 |
| Rodriguez-Jimenez, C | 1 |
| Caino, S | 1 |
| Fano, V | 1 |
| Heath, KE | 1 |
| García-Miñaúr, S | 1 |
| Palomares-Bralo, M | 1 |
| Santos-Simarro, F | 1 |
1 review available for flumazenil and Dominant Hereditary Sensory Neuropathy, Type III
| Article | Year |
|---|---|
Delineation of the clinical and radiological features of Stuve-Wiedemann syndrome childhood survivors, four new cases and review of the literature.
Topics: Abnormalities, Multiple; Bone Diseases, Developmental; Bone Diseases, Metabolic; Child, Preschool; C | 2021 |